Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.27B |
| 2 |
Blackrock
BLK
|
+$1.21B |
| 3 |
PG&E
PCG
|
+$1.17B |
| 4 |
Alibaba
BABA
|
+$1.12B |
| 5 |
T-Mobile US
TMUS
|
+$826M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$1.34B |
| 2 |
Boston Scientific
BSX
|
+$1.26B |
| 3 |
American Express
AXP
|
+$1.23B |
| 4 |
GE Aerospace
GE
|
+$1.1B |
| 5 |
Visa
V
|
+$993M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.88% |
| 2 | Healthcare | 16.37% |
| 3 | Consumer Discretionary | 13.18% |
| 4 | Financials | 11.24% |
| 5 | Communication Services | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
HUTCHMED
HCM
$2.17B
| $7.06M | ﹤0.01% |
255,980
-442,398
| -63% | -$9.6M |
|
|
UROV
1852
DELISTED
Urovant Sciences Ltd.
UROV
| $7.01M | ﹤0.01% |
712,736
-180,800
| -20% | -$1.73M |
|
1853
Verrica Pharmaceuticals
VRCA
$87.3M
| $7M | ﹤0.01% |
63,568
| – | – |
|
1854
Nokia
NOK
$52.3B
| $6.99M | ﹤0.01% |
1,589,549
-746,243
| -32% | -$2.82M |
|
1855
Byline Bancorp
BY
$1.76B
| $6.97M | ﹤0.01% |
531,900
-33,500
| -6% | -$383K |
|
1856
Trip.com Group
TCOM
$29.1B
| $6.94M | ﹤0.01% |
267,789
-671
| -0.2% | -$16.9K |
|
1857
Advance Auto Parts
AAP
$3.49B
| $6.94M | ﹤0.01% |
48,702
+31,481
| +183% | +$4M |
|
1858
EverQuote
EVER
$906M
| $6.91M | ﹤0.01% |
+118,797
| New | +$5.58M |
|
1859
CytomX Therapeutics
CTMX
$754M
| $6.91M | ﹤0.01% |
828,973
+360
| +0% | +$3.34K |
|
1860
ASE Group
ASX
$82.2B
| $6.88M | ﹤0.01% |
1,516,100
+1,515,930
| +891,724% | +$6.47M |
|
1861
Compass Minerals
CMP
$1.15B
| $6.84M | ﹤0.01% |
140,255
-2,177
| -2% | -$101K |
|
1862
AMN Healthcare
AMN
$1.4B
| $6.81M | ﹤0.01% |
150,484
-167,006
| -53% | -$7.99M |
|
1863
iShares ESG Aware MSCI EM ETF
ESGE
$6.73B
| $6.77M | ﹤0.01% |
211,202
+856
| +0.4% | +$25.7K |
|
1864
Black Hills Corp
BKH
$5.69B
| $6.73M | ﹤0.01% |
118,721
-484
| -0.4% | -$29.3K |
|
1865
Kiniksa Pharmaceuticals
KNSA
$5.93B
| $6.7M | ﹤0.01% |
262,806
+140,906
| +116% | +$2.94M |
|
1866
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$10B
| $6.69M | ﹤0.01% |
285,706
-2,796,525
| -91% | -$62.7M |
|
|
ECHO
1867
DELISTED
Echo Global Logistics, Inc.
ECHO
| $6.66M | ﹤0.01% |
308,200
+173,900
| +129% | +$3.27M |
|
|
AMTI
1868
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $6.66M | ﹤0.01% |
+265,014
| New | +$6.69M |
|
1869
Legacy Housing
LEGH
$694M
| $6.61M | ﹤0.01% |
465,127
-48,560
| -9% | -$551K |
|
1870
Texas Pacific Land
TPL
$23.5B
| $6.58M | ﹤0.01% |
99,585
+38,421
| +63% | +$2.36M |
|
1871
Qiagen
QGEN
$8.72B
| $6.55M | ﹤0.01% |
143,692
+84,730
| +144% | +$3.79M |
|
1872
X4 Pharmaceuticals
XFOR
$460M
| $6.5M | ﹤0.01% |
23,260
| – | – |
|
1873
Broadridge
BR
$19B
| $6.49M | ﹤0.01% |
51,436
+4,212
| +9% | +$488K |
|
|
CRON
1874
Cronos Group
CRON
$1.14B
| $6.44M | ﹤0.01% |
+1,069,400
| New | +$6.54M |
|
1875
AnaptysBio
ANAB
$1.68B
| $6.43M | ﹤0.01% |
288,066
+90,838
| +46% | +$1.66M |
|
Similar funds
Fidelity Investments's Q2 2020 Portfolio in Review
As of Q2 2020, Fidelity Investments held 4,490 positions worth $909B, up 26% from $722B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Fidelity Investments's Q2 2020 filing shows 334 new, 1,365 increased, 1,743 reduced and 502 closed positions. Its largest new stake was Royalty Pharma: 16,356,491 shares worth $743M. The largest sale was iShares US Treasury Bond ETF, an estimated $1.34B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Fidelity Investments's largest Q2 2020 buy was Royalty Pharma: 16,356,491 shares worth $743M.
- Fidelity Investments added most to Regeneron Pharmaceuticals in Q2 2020, an estimated $2.27B increase.
- Fidelity Investments's biggest Q2 2020 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.34B.
- Fidelity Investments fully exited Sprint Corporation in Q2 2020, selling an estimated $225M.
- Fidelity Investments's ten largest holdings make up 28% of its $909B portfolio in Q2 2020.
- Fidelity Investments opened 334 new positions and closed 502 in Q2 2020.
- Fidelity Investments's portfolio value rose 26% quarter-over-quarter to $909B.
Based on Fidelity Investments's 13F filing for Q2 2020, filed 13 Aug 2020.